GranBio Acquires 100% Equity of the North American Biotechnology Firm American Process Inc. (API)
The acquisition of American Process Inc’s technologies, intellectual property portfolio and physical assets strengthens GranBio’s market leading position in the deployment of highly competitive industrial processes for conversion of biomass to renewable fuels, chemicals, and nanocellulose.
GranBio completed the acquisition of 100% equity in American Process Inc. and affiliate companies including AVAPCO LLC and API Intellectual Properties Holdings. The acquired assets include the Alpena Biorefinery in Alpena Michigan, the Thomaston Biorefinery and R&D center in Thomaston, Georgia, operations, research, and business development staff and an extensive intellectual property portfolio in the biorefinery, biofuels, biochemicals, and nanocellulose fields with over 200 granted and pending patents.
“Acquiring the GreenPower+®, GreenBox+®, and AVAP® biorefinery technologies and the BioPlus® Nanocellulose Technology and their associated world-class demonstration plants and exceptional operations and R&D staff is part of GranBio’s mission to become a global leader in the bioeconomy. As evidenced by the construction and operation of the first commercial scale cellulosic ethanol plant in Brazil, GranBio is deeply committed to launching innovative biotechnologies that build a better and more environmentally safe planet for the next generations” said GranBio’s president, Bernardo Gradin.
GranBio is an industrial biotechnology company focused on commercial deployment of technologies for the production of biofuels, biochemicals, and advanced renewable materials including nanocellulose.
GranBio operates the first commercial scale cellulosic ethanol plant in the Southern Hemisphere. The biorefinery, named Bioflex 1, is located in Alagoas, Brazil and converts biomass from sugarcane residue, straw and bagasse into “second-generation” cellulosic ethanol.